News | March 14, 2026
Biogen unveils promising new data for Salanersen in kids with SMA
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
One task, one interaction, one pair, experts advocate
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The conflict is also triggering a widening public health emergency
The Phase 1 dose-escalation trial enrolled 25 evaluable patients and was designed to determine the recommended dose of LYMPHIR
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Marks significant milestone for breakthrough biologic to treat rare blood cancers
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise
Subscribe To Our Newsletter & Stay Updated
